Outstanding young researcher
The expert jury very carefully examined the projects based on the evaluation criteria innovation, benefit for patients and applicability. The three best research projects were presented by the students at pharmaKON future on 10 May 2022 at the Renaissance Hotel Vienna, and the results were presented to an expert audience from the industry. Caroline Schätz, a master student in “Medical and Pharmaceutical Biotechnology” at IMC Krems, was awarded second place for her research work titled “Generation of living blood vessels from hypoimmunogenic human pluripotent stem cells”.
Development of vascular grafts
Caroline Schätz’s research focused on the development of vascular grafts for the treatment of cardiovascular diseases to replace affected human blood vessels.
Caroline Schätz had the opportunity to spend her PTS at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, as part of her Marshall Plan Scholarship to intensify her research at the renowned institutions.
“We are very proud that we managed to achieve a top ranking in the Young Pharma Award again this year. This proves that our graduates’ final theses, which are generated in cooperation with international research institutes, are of outstanding quality,” says the head of the Institute of Medical and Pharmaceutical Biotechnology, Prof.(FH) Priv.-Doz. Dr. Harald Hundsberger.
About the Young Pharma Award
pharmaKON is the annual get-together for the Austrian pharmaceutical industry and healthcare sector. Since 2019, the YOUNG PHARMA AWARD has been a special highlight of pharmaKON. Students have the opportunity to present their research projects directly to the industry. A perfect bridge is created between the students and the Austrian pharmaceutical industry. Student research projects that are scientifically sound were eligible to participate.
